TRDA   $11.98  0.84% Market Closed After Close 11.94 -0.33%

Entrada Therapeutics, Inc.
Total Cash 469.75M
totalCashPerShare 13.35
EBITDA 96.87M
Total Debt 64.44M
quickRatio 5.58
currentRatio 5.705
Total Revenue 239.40M
debtToEquity 14.989
Revenue/Share 7.128
ROA 0.10857
ROE 0.32801
grossProfits
freeCashflow 25.43M
operatingCashflow -14.19M
earningsGrowth
revenueGrowth 4.212
grossMargins 0.53581
ebitdaMargins 0.40463
operatingMargins 0.56416
profitMargins 0.43627998
enterpriseValue 219.97M
forwardPE -5.6890244
floatShares 18.20M
sharesOutstanding 37.41M
sharesShort 1.65M
sharesShortPriorMonth 2.17M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.13%
heldPercentInstitutions 0.81%
Short Ratio help_outline 9.56%
shortPercentOfFloat 0.07%
impliedSharesOutstanding
bookValue 7.534
Price To Book help_outline 2.48
earningsQuarterlyGrowth
netIncomeToCommon 104.44M
trailingEps 1.44%
forwardEps -3.28%
enterpriseToEbitda 2.27
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.74 4Q 2024
institutionsCount 146
lastUpdated Nov. 7, 2024, 6:59 a.m.